Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My Email to PTSC

My Email to PTSC

posted on Apr 22, 2006 09:06AM
Dear PTSC

As a long time and sizeable shareholder, I was dismayed by the deeply negative and unbalanced assessment of my company written by Maxwell Murphy. The article to which I am referring is the following:

IN THE MONEY: Patriot Scientific Dividend Well Not Endless

1,228 words

21 April 2006

06:37 pm GMT

Dow Jones News Service

English

(c) 2006 Dow Jones & Company, Inc.

By Maxwell Murphy

A Dow Jones Newswires Column

It is my sincere hope (and even respectful demand) that David Pohl, PTSC, and TPL issue a widely released point-by-point rebuttal before Murphy’s diatribe becomes entrenched gospel in the minds of thousands of investors across the world.

Late Monday will be too late.

Thank you.

TPS

Share
New Message
Please login to post a reply